Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Similar Posts
Baby formula recalled over bacteria contamination fears
Reckitt are recalling batches of Nutramigen powders after finding bacteria in an “isolated overseas sample”.
To reduce cancer risk, skip the alcohol, report suggests: ‘No safe amount’
For those participating in “Dry January,” another potential benefit of giving up alcohol has emerged. Giving up alcoholic drinks — or reducing the amount that’s consumed — could reduce the risk of getting oral or esophageal cancer, according to a special report published in The New England Journal of Medicine on Dec. 28. Researchers from…
Pentagon waited three days to inform White House that the defense secretary was hospitalized in ICU
WASHINGTON — Amid tensions in the Middle East, Secretary of Defense Lloyd Austin was hospitalized, including spending four days in the intensive care unit, according to two senior administration officials. The Pentagon did not inform senior officials in the White House’s National Security Council of Austin’s hospitalization until Thursday — three days after he arrived…
Midwife quit over ‘unsafe care’ and staffing
Other NHS workers have risen in number five times more than midwives over the past decade.
The Future of Food: Lab-Grown Meat and Sustainable Dining
The way we eat has always evolved with technology—from the invention of agriculture thousands of years ago to the rise of fast food in the 20th century. Now, a new frontier is emerging in the food industry: lab-grown meat. Sometimes called “cultivated meat,” this innovation promises to transform how we produce and consume protein, offering…
Edwards Lifesciences cooperating with EU antitrust regulators | Reuters News Agency
Health 27 September 2023, 2:03 pm 1 minute Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on…
